Henan Lingrui Pharmaceutical Co., Ltd.

SHSE:600285 Stock Report

Market Cap: CN¥11.7b

Henan Lingrui Pharmaceutical Dividends and Buybacks

Dividend criteria checks 5/6

Henan Lingrui Pharmaceutical is a dividend paying company with a current yield of 3.84% that is well covered by earnings.

Key information

3.8%

Dividend yield

0.007%

Buyback Yield

Total Shareholder Yield3.9%
Future Dividend Yield5.9%
Dividend Growth13.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.800
Payout ratio66%

Recent dividend and buyback updates

No updates

Recent updates

An Intrinsic Calculation For Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Suggests It's 44% Undervalued

Oct 28
An Intrinsic Calculation For Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Suggests It's 44% Undervalued

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Surges 33% Yet Its Low P/E Is No Reason For Excitement

Oct 13
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Surges 33% Yet Its Low P/E Is No Reason For Excitement

If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

Aug 07
If EPS Growth Is Important To You, Henan Lingrui Pharmaceutical (SHSE:600285) Presents An Opportunity

A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Jul 03
A Look At The Fair Value Of Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285)

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 600285's dividend payments have been volatile in the past 10 years.

Growing Dividend: 600285's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Henan Lingrui Pharmaceutical Dividend Yield vs Market
How does 600285 dividend yield compare to the market?
SegmentDividend Yield
Company (600285)3.8%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast (600285) (up to 3 years)5.9%

Notable Dividend: 600285's dividend (3.84%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 600285's dividend (3.84%) is in the top 25% of dividend payers in the CN market (2.17%)


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (66.3%), 600285's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (73.7%), 600285's dividend payments are covered by cash flows.


Discover strong dividend paying companies